Nordic markets still healthy as Meda signs a refi
Meda, the Swedish pharmaceutical group, has signed a Skr2.15bn (Eu230m) refinancing deal. It was oversubscribed and increased by Skr450m, showing that the Nordic market for mid-market loans is still strong. Find out later today online and in EuroWeek on Friday what the market thinks of it.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts